Differential effects of the calcium entry blocker D 600 on contractions of rat and guinea-pig aortas, elicited by various alpha-1 adrenoceptor agonists
- PMID: 6143818
Differential effects of the calcium entry blocker D 600 on contractions of rat and guinea-pig aortas, elicited by various alpha-1 adrenoceptor agonists
Abstract
Contractions of rat and guinea-pig aortas to the alpha-adrenoceptor agonists I-norepinephrine, cirazoline , St 587, clonidine and Sgd 101/75 and the effect of calcium entry blockade by D 600 on the responses were evaluated. In rat aorta, D-600 (10(-8) to 10(-5) M) effectively and concentration-dependently reduced the maximal responses to St 587, clonidine and Sgd 101/75 (maximal percentage inhibition 84 +/- 2.1, 86 +/- 4.1 and 65 +/- 2.8, n = 5-6, respectively) in contrast to those of I-norepinephrine and cirazoline (maximal percentage inhibition 23 +/- 2.1 and 21 +/- 4.1, n = 6, respectively). Reducing the receptor number on rat aorta by approximately 85% by means of the irreversible blocker dibenamine did not result in a greater sensitivity of norepinephrine-induced contractions toward D 600. Prazosin was found 800 to 1000 times more potent than yohimbine in antagonizing the contractile effects of St 587, clonidine and cirazoline on rat and guinea-pig aortas. No difference existed between the pA2 values of prazosin and yohimbine against the different agonists; the pA2 values of prazosin and yohimbine were significantly higher in rat aorta than those in guinea-pig aorta. The results can be explained by assuming the existence of two different agonist recognition sites on the alpha-1 adrenoceptor on rat aorta, whereas the alpha-1 adrenoceptor on guinea-pig aorta contains one agonist recognition site only. The architecture of the alpha-1 adrenoceptor on rat aorta must therefore be different from that in guinea-pig aorta.
Similar articles
-
The contractions induced in rat and guinea-pig aortic strips by the alpha 2-adrenoceptor selective agonists B-HT 920 and UK 14,304 are mediated by alpha 1-adrenoceptors.Eur J Pharmacol. 1984 Sep 17;104(3-4):197-203. doi: 10.1016/0014-2999(84)90394-7. Eur J Pharmacol. 1984. PMID: 6149946
-
Calcium utilization in the vasoconstriction to enantiomers of SK&F 89748-A.J Pharmacol Exp Ther. 1985 Feb;232(2):330-6. J Pharmacol Exp Ther. 1985. PMID: 2857195
-
Nifedipine and alpha adrenoceptors in rat aorta. II. Role of extracellular calcium in enhanced alpha-2 adrenoceptor-mediated contraction in diabetes.J Pharmacol Exp Ther. 1984 Dec;231(3):603-9. J Pharmacol Exp Ther. 1984. PMID: 6094794
-
Sgd 101/75: a sympathomimetic that can be used to identify a new subtype of alpha-adrenoceptor, the alpha 1s-adrenoceptor.Methods Find Exp Clin Pharmacol. 1983 Sep;5(7):425-34. Methods Find Exp Clin Pharmacol. 1983. PMID: 6142147 Review.
-
The relationship of receptor reserve and agonist efficacy to the sensitivity of alpha-adrenoceptor-mediated vasopressor responses to inhibition by calcium channel antagonists.Ann N Y Acad Sci. 1988;522:361-76. doi: 10.1111/j.1749-6632.1988.tb33377.x. Ann N Y Acad Sci. 1988. PMID: 2897818 Review. No abstract available.
Cited by
-
Influence of calcium entry blockade on alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in the forearm of hypertensive patients.Eur J Clin Pharmacol. 1987;32(2):115-20. doi: 10.1007/BF00542182. Eur J Clin Pharmacol. 1987. PMID: 3034623 Clinical Trial.
-
Existence of two components in the tonic contraction of rat aorta mediated by alpha 1-adrenoceptor activation.Br J Pharmacol. 1991 Jan;102(1):215-21. doi: 10.1111/j.1476-5381.1991.tb12156.x. Br J Pharmacol. 1991. PMID: 1675145 Free PMC article.
-
Pharmacological properties of alpha 1-adrenoceptor-mediated vasoconstrictions in dog and monkey lingual arteries: evidence for subtypes of alpha 1-adrenoceptors.Heart Vessels. 1992;7(2):82-90. doi: 10.1007/BF01744453. Heart Vessels. 1992. PMID: 1356961
-
Proceedings of the British Pharmacological Society Meeting. 3rd-5th January 1990. Abstracts.Br J Pharmacol. 1990 Apr;99 Suppl(Suppl):1P-302P. Br J Pharmacol. 1990. PMID: 2317620 Free PMC article. No abstract available.
-
2-Naphthalenesulphonyl L-aspartyl-(2-phenethyl)amide (2-NAP)--a selective cholecystokinin CCKA-receptor antagonist.Br J Pharmacol. 1993 Mar;108(3):734-40. doi: 10.1111/j.1476-5381.1993.tb12870.x. Br J Pharmacol. 1993. PMID: 7682135 Free PMC article.